The Alkaloid #32: What the Flame Adds
Heating THC produced 79 small-molecule breakdown products in a new lab study. What the experiment shows, what it cannot tell us, and why better testing should serve people who use cannabis.
Heating THC produced 79 small-molecule breakdown products in a new lab study. What the experiment shows, what it cannot tell us, and why better testing should serve people who use cannabis.
A new US survey records health changes people attribute to five psychoactive drugs. Its small subgroups and different recall windows matter as much as the headlines.
Gabon wants a share of the ibogaine boom. New reporting exposes the distance between paying for bark and sharing the value created afterward.
Kratom leaf and concentrated 7-OH can share a name on the shelf without sharing a chemical profile. The distinction matters for safety, research and regulation.
Before a cannabis jar reaches the counter, someone grows, harvests and cures it. Massachusetts' repeal debate is also about those paychecks, the businesses behind them and the limits of promises about what comes next.
Massachusetts could preserve an adult's right to possess cannabis while closing recreational shops and ending home grows. Who benefits—and what would police be asked to do again?
The FDA is asking who delivers psychedelic care, how patients are protected, and who pays. The practical work extends well beyond the drug.
Cannabis-friendly social spaces need more than a place to consume. St. Louis offers a look at the work of hosting.
THC drinks borrow the rituals of a night out. Familiar packaging does not make the intoxicant familiar.
Cannabis gets an official place in the event program. What two upcoming events promise, and what a small music study can actually tell us.
A new cannabis genetics paper cataloged 227 volatile terpenes across six cultivars. The fun part is what those compounds reveal about flower, genes, and why your nose keeps finding more than a THC label can say.
Everyone reported that the federal hemp ban slipped to December 11. It hasn't passed the House, and the delay is narrower than the coverage suggests: it turns on whether a molecule is capable of being naturally produced, not on how it was actually made. What that sorts, and what it strands.